Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
University of Kentucky
BeiGene
Trishula Therapeutics, Inc.
Eastern Cooperative Oncology Group
Ohio State University Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
University of California, Davis
Vanderbilt-Ingram Cancer Center